Overview
Decisions in Interventional Management of Acute Pulmonary Embolism
PE Touchpoint
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Clinicians who diagnose and treat patients with acute pulmonary embolism (PE) need to be updated on guidelines and trials regarding the current interventional therapeutic landscape, particularly with catheter-directed devices. In this targeted 30-minute CME touchpoint, Dr. Adrian Messerli from UK HealthCare discusses the latest recommendations for the management of PE. This interactive activity will feature images, easy-to-read charts, and graphs as well as expert video commentary.
Featured topic areas include:
• Identifying candidates for interventional procedures
• Latest clinical trial data with catheter directed devices
• Procedural case discussion
This activity is intended for interventional cardiologists, interventional radiologists, vascular surgeons, and other healthcare clinicians interested in treating patients with venous disease.
Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis, is more common than many clinicians realize. Though there are many treatment strategies available for PE, one strategy, CDI continues to be underutilized despite its benefits compared to older interventions (e.g. surgical embolectomy, systemic thrombolytics) because of a lack of clinician understanding of CDI and the evidence for its use in acute PE. Clinicians need to know about the multitude of CDI options available, their indications, what patients are eligible, and the latest safety and efficacy data for these devices. Once clinicians overcome these gaps, they will be better able to ensure the optimal use of CDI and guarantee the best outcomes for their patients with acute PE.
Upon completion of this activity, participants will be able to:
• Discuss risk stratification of patients with pulmonary embolism to identify candidates for interventional therapy
• Interpret available data on thrombolysis for pulmonary embolism using catheter-directed approaches, with or without mechanical clot lysis
• Outline available interventional strategies for treating acute pulmonary embolism
• Discuss risk stratification of patients with pulmonary embolism to identify candidates for interventional therapy
• Interpret available data on thrombolysis for pulmonary embolism using catheter-directed approaches, with or without mechanical clot lysis
• Outline available interventional strategies for treating acute pulmonary embolism
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Boston Scientific Corporation.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Adrian Messerli, MD
Director, Cardiac Catheterization Laboratories
UK HealthCare
Lexington, KY
Director, Cardiac Catheterization Laboratories
UK HealthCare
Lexington, KY
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Adrian Messerli, MD, (Faculty)
Consultant (Occasional) and Speakers' Bureau: Boston Scientific Corporation
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Off-label PE use of Uni-fuse, Cragg-McNamara, Bashir endovascular, and AngioVac devices.
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
(NOTE: Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.)
This enduring material initially launched on February 26, 2021. The content was re-reviewed for scientific validity and accuracy on February 16, 2022 and April 7, 2023. Accreditation for this activity will expire on February 26, 2024.
